[1]
|
Oscar, M.R., Raul, G.G., Jesus, M.A., et al. (2009) Metastasis of renal clear-cell carcinoma to the oral mucosa, an atypical location. Medicina Oral, Patologia Oral y Cirugia Bucal, 14, 601-604.
|
[2]
|
Pritchyk, K.M., Schiff, B.A., Newkirk, K.A., et al. (2002) Metastatic renal carcinoma to the head and neck. The La- ryngoscope, 112, 1598-1602.
doi:10.1097/00005537-200209000-00012
|
[3]
|
Montie, J.E., Stewart, B.H., Straffon, R.A., et al. (1977) The role of adjunctive nephrectomy in patients with metastatic renal cell carcinoma. The Journal of Urology, 117, 272-275.
|
[4]
|
Tomera, K.M., Farrow, G.M. and Lieber, M.M. (1983) Sarcomatoid renal cell carcinoma. The Journal of Urology, 130, 657-659.
|
[5]
|
Bertoni, F., Ferri, C., Benati, A., et al. (1987) Sarcomatoid renal cell carcinoma of kidney. The Journal of Urology, 137, 25-28.
|
[6]
|
Ro, J.Y., Ayala, A.G., Sella, A., et al. (1987) Sarcoma- toid renal cell carcinoma, clinicopathologic. A study of 42 cases. Cancer, 59, 516-526.
doi:10.1002/1097-0142(19870201)59:3<516::AID-CNCR2820590327>3.0.CO;2-W
|
[7]
|
Shuch, B., Riggs, S.B., LaRochelle, J.C., et al. (2008) Neoadjuvant targeted therapy and advanced kidney cancer: Observations and implications for a new treatment paradigm. BJU International, 102, 692-696.
doi:10.1111/j.1464-410X.2008.07660.x
|
[8]
|
Hirshberg, A., Leibovich, P. and Buchner, A. (1993) Me- tastasis to the oral mucosa: Analysis of 157 cases. Journal of Oral Pathology & Medicine, 22, 385-390.
doi:10.1111/j.1600-0714.1993.tb00128.x
|
[9]
|
Fukuda, M., Miyata, M., Okabe, K., et al. (2002) A case series of 9 tumors metastatic to the oral and maxillofacial region. Journal of Oral and Maxillofacial Surgery, 60, 942-944. doi:10.1053/joms.2002.33868
|
[10]
|
Meyer, I. and Shklar, G. (1965) Malignant tumors metastatic to mouth and jaws. Oral Surgery, Oral Medicine, Oral Pathology, 20, 350-362.
doi:10.1016/0030-4220(65)90167-2
|
[11]
|
Astacio, J.N. and Alfano, C. (1969) Oral mucosa metastasis from gastric adenocarcinoma. Oral Surgery, Oral Medicine, Oral Pathology, 28, 859-861.
doi:10.1016/0030-4220(69)90339-9
|
[12]
|
Nishmura, Y., Yakata, H., Kawasaki, T., et al. (1982) Metastatic tumors of the mouth and jaws: A review of the Japanese literature. Journal of Maxillofacial Surgery, 4, 253-258.
|
[13]
|
Zachriades, N. (1980) Neoplasms metastatic to the mouth, jaw and surrounding tissues. Journal of Cranio-Maxillofacial Surgery, 17, 283-290.
doi:10.1016/S1010-5182(89)80098-8
|
[14]
|
Zohar, Y., Ben-Tovim, R., Gal, R., et al. (1985) Metastatic carcinoma of oral soft tissue. Head & Neck Surgery, 7, 484-486. doi:10.1002/hed.2890070609
|
[15]
|
Roser, S.M., Nicholas, T.R. and Hirose, F.M. (1976) Me- tastatic chondrosarcoma to the maxilla: Review of the lit- erature and report of case. Journal of oral surgery, 34, 1012-1015.
|
[16]
|
Glaser, C., Lang, S., Pruckmayer, M., et al. (1997) Clini- cal manifestations and diagnostic approach to metastatic cancer of the mandible. International Journal of Oral and Maxillofacial Surgery, 26, 365-368.
doi:10.1016/S0901-5027(97)80798-9
|
[17]
|
NCCN Clinical Practice Guidelines in Oncology (2010) Kidney Cancer.
http://www.tri-kobe.org/nccn/guideline/urological/english/kidney.pdf
|
[18]
|
Wilhelm, S.M., Carter, C., Tang, L., et al. (2004) Bay 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis. Cancer Research, 64, 7099-7109.
doi:10.1158/0008-5472.CAN-04-1443
|
[19]
|
Bukowski, R.M., Eisen, T., Szczylik, C., et al. (2007) Final results of the randomized phase trial of Sorafenib in advanced renal cell carcinoma: Survival and biomarker analysis. Journal of Clinical Oncology, 25, 5023.
|
[20]
|
Motzer, R.J., Rini, B.I., Bukowski, R.M., et al. (2006) Activity of SU 11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma. Journal of Clinical Oncology, 24, 16-24.
doi:10.1200/JCO.2005.02.2574
|
[21]
|
Lacouture, M.E., Reilly, L.M., Gerami, P., et al. (2008) Hand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinib. Annals of Oncology, 19, 1955-1961. doi:10.1093/annonc/mdn389
|
[22]
|
Nagengast, W.B., Lub-de Hooge, M.N., Oosting, S.F., et al. (2010) VEGF-PET imaging is a noninvasive biomarker showing differential changes in the tumor during sunitinib treatment. Cancer Research, 71, 143-153.
doi:10.1158/0008-5472.CAN-10-1088
|
[23]
|
Llovet, J.M., Ricci, S., Mazzaferro, V., et al. (2008) Soraf-enib in advanced hepatocellular carcinoma. The New England Journal of Medicine, 359, 378-390.
doi:10.1056/NEJMoa0708857
|